Earnings Feed
Start Free
STAAR SURGICAL CO·4

Mar 16, 5:00 PM ET

Foust Warren 4

4 · STAAR SURGICAL CO · Filed Mar 16, 2026

Research Summary

AI-generated summary of this filing

Updated

STAAR (STAA) Interim Co‑CEO Warren Foust Receives RSU Award, Converts Vested RSUs

What Happened Warren Foust, Interim Co‑CEO and President & COO of STAAR Surgical (STAA), had multiple restricted stock unit (RSU) events reported on Form 4. On March 12 and March 14, 2026 he converted vested RSUs into 37,500 shares (8,175 + 19,550 + 9,775) at $0.00 per share and those same amounts were reported as disposed the same days. On March 13, 2026 he was granted 45,117 new RSUs (annual award) at $0.00 per RSU. All transactions are reported as derivative activity (codes M = exercise/conversion; A = award/grant).

Key Details

  • Transaction dates and amounts:
    • 2026-03-12: Conversion (M) of 8,175 vested RSUs → acquired 8,175 shares @ $0.00; same day disposition of 8,175 shares @ $0.00.
    • 2026-03-13: Grant (A) of 45,117 RSUs @ $0.00 (annual award).
    • 2026-03-14: Conversions (M) of 19,550 and 9,775 vested RSUs → acquired and same‑day disposed at $0.00 (each).
  • Net/ongoing change: The filing shows 45,117 newly granted RSUs (subject to future vesting). The vested RSUs converted on 3/12–3/14 were also reported as disposed the same days (no retained shares from those vested conversions reflected in the filing).
  • Footnotes: Vesting schedules—prior RSUs from 2024 and 2025 vested in thirds (F1, F3, F4); the March 13, 2026 RSU award vests 1/3 annually from 2027–2029 (F2). Each RSU equals one share on vesting (F6). F5 notes other previously granted RSUs remain subject to future vesting.
  • Shares owned after transaction: the filing does not disclose total beneficial ownership (not provided in the summary data).
  • Timeliness: Form filed 2026-03-16 for transactions 3/12–3/14; no late filing is indicated.

Context

  • The conversions labeled "M" are derivative exercises/conversions (here, RSUs converting into common shares upon vesting). The matched same‑day disposals are consistent with shares being surrendered or withheld (commonly to satisfy tax withholding), as the filing shows zero cash consideration; the filing does not detail tax withholding mechanics.
  • The March 13 entry is an award of RSUs (A) that will vest over future years per the footnote schedule and therefore does not represent immediately tradable shares.

Insider Transaction Report

Form 4
Period: 2026-03-12
STAAR SURGICAL COSTAA
Foust Warren
Interim Co-CEO and Pres. & COO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-12+8,175→ 34,263 total
  • Exercise/Conversion

    Common Stock

    [F3]
    2026-03-14+19,550→ 53,813 total
  • Exercise/Conversion

    Common Stock

    [F4][F5]
    2026-03-14+9,775→ 63,588 total
  • Exercise/Conversion

    Restricted Stock Units

    [F6][F1]
    2026-03-12−8,175→ 8,175 total
    Exercise: $0.00→ Common Stock (8,175 underlying)
  • Award

    Restricted Stock Units

    [F6][F2]
    2026-03-13+45,117→ 45,117 total
    Exercise: $0.00→ Common Stock (45,117 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F6][F3]
    2026-03-14−19,550→ 39,101 total
    Exercise: $0.00→ Common Stock (19,550 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F6][F4]
    2026-03-14−9,775→ 19,551 total
    Exercise: $0.00→ Common Stock (9,775 underlying)
Footnotes (6)
  • [F1]Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,175 shares) on March 12, 2025, 1/3 (8,175 shares) on March 12, 2026, and will vest as to 1/3 (8,175 shares) on March 12, 2027.
  • [F2]Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (15,039 shares) on March 13, 2027, 1/3 (15,039 shares) on March 13, 2028, and 1/3 (15,039 shares) on March 13, 2029.
  • [F3]Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (19,550 shares) on March 14, 2026, and will vest as to 1/3 (19,550 shares) on March 14, 2027, and 1/3 (19,551 shares) on March 14, 2028.
  • [F4]Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (9,775 shares) on March 14, 2026, and will vest as to 1/3 (9,775 shares) on March 14, 2027, and 1/3 (9,776 shares) on March 14, 2028.
  • [F5]Includes previously granted RSUs, which are subject to future vesting.
  • [F6]Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.
Signature
/s/ Warren Foust|2026-03-16

Documents

1 file
  • 4
    ownership.xmlPrimary

    4